Evaluation of Next-Generation Sequencing as a clinical and research modality in the diagnosis of hereditary breast cancer
Next-Generation Sequencing has opened the doors to nearly limitless amounts of genomic data, but the clinical utility of this data is not yet clear. From examining at sequencing data of known familial cancer genes in hereditary cancer patients, the NCGENES study found a clear molecular diagnosis in...
Main Author: | Dougherty, Kristen Elizabeth |
---|---|
Language: | en_US |
Published: |
2016
|
Subjects: | |
Online Access: | https://hdl.handle.net/2144/16120 |
Similar Items
-
Identification of Novel Candidate Genes for Familial Thyroid Cancer by Whole Exome Sequencing
by: Antiñolo, G., et al.
Published: (2023) -
Identification of the CFTR c.1666A>G Mutation in Hereditary Inclusion Body Myopathy Using Next-Generation Sequencing Analysis
by: Yan Lu, et al.
Published: (2018-05-01) -
Corrigendum: Identification of the CFTR c.1666A>G Mutation in Hereditary Inclusion Body Myopathy Using Next-Generation Sequencing Analysis
by: Yan Lu, et al.
Published: (2018-08-01) -
Applications of Next Generation Sequencing to the Analysis of Familial Breast/Ovarian Cancer
by: Veronica Zelli, et al.
Published: (2020-01-01) -
Whole‐Exome Sequencing of Germline Variants in Non‐BRCA Families with Hereditary Breast Cancer
by: Bajalica‐lagercrantz, S., et al.
Published: (2022)